ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Bristol-Myers Squibb Co.
(NY:
BMY
)
46.85
USD
+0.41 (+0.88%)
Official Closing Price
/ Updated:
4:15 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
7,155,486
Open
46.60
Bid (Size)
46.83 (2400)
Ask (Size)
46.84 (1500)
Prev. Close
46.44
Today's Range
46.46 - 47.00
52wk Range
30.64 - 49.57
Shares Outstanding
1,642,551,939
Dividend Yield
2.95%
Featured News
More News
Ex-Bristol-Myers executive admits to insider trade
June 10, 2013
Robert Ramnarine, who was involved with evaluating potential acquisition targets for Bristol-Myers Squibb, admitted to illicit gains from trading in stock options of several of the pharmaceutical...
Read More
category
Market News
,
Biotechnology
,
General
, and 7 more.
from
MarketWatch
New Stock Coverage: Check Out Marriott's Five-Star Welcome
May 30, 2013
Wall Street ratings agencies set the tone for today's stock market.
Read More
category
S
,
MAR
,
BMY
from
Minyanville Headlines
Featured News
Read More
Stock Upgrades: Dice Holdings Is on a Roll
May 22, 2013
category
BMY
from
Minyanville Headlines
In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure
May 08, 2013
category
MRK
,
GILD
,
BMY
from
Minyanville Headlines
Stocks Survive Once Again
April 25, 2013
category
AMZN
,
QCOM
,
AAPL
, and 2 more.
from
Minyanville Headlines
Updates, advisories and surprises
April 25, 2013
category
SOX
,
Earnings
,
ZNGA
, and 16 more.
from
MarketWatch
Stock futures up ahead of Dow Chemical, claims
April 25, 2013
category
Earnings
,
VZ
,
UL
, and 37 more.
from
MarketWatch
Amazon, Starbucks, UPS are stocks to watch
April 25, 2013
category
TWC
,
Earnings
,
CSTR
, and 46 more.
from
MarketWatch
More News
Read More
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
Today 10:13 EDT
category
NYSE:MRK
,
NYSE:PFE
,
NYSE:BMY
, and 1 more.
from
Forbes Real Time
Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers
Today 9:00 EDT
from
Business Wire News Releases
Insider Trading Investment for Bank of America, Hewlett-Packard, Bristol Myers Squibb, Annaly Capital Management, Walt Disney, and American Capital Agency
Today 8:55 EDT
from
PR Newswire
Key to Success, How to Profit: FSLR, NWSA, BMY and LULU
Today 8:00 EDT
from
Marketwired News Releases
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
from
StreetInsider.com News Articles
USMV, BMY, PEP, CB: ETF Outflow Alert
June 17, 2013
category
ETFs
from
ETF Channel
Cramer: A 'Nightmare Scenario' for Bulls and Bears
June 17, 2013
category
General Mills Inc
,
Squawk on the Street
,
tv6in60
, and 2 more.
from
CNBC.com News
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
category
NYSE:PFE
,
NYSE:BMY
from
Forbes Real Time
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
June 17, 2013
from
PR Newswire
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
5
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
See All Articles
»